Anbio Biotechnology (NNNN) Registration filing summary

Management team and governance

• CEO is Michael Lau, who also serves as Principal Executive Officer.

• Suki Song is the Chief Financial Officer and Principal Accounting and Financial Officer.

• Cany Xu serves as a Director.

• The company is incorporated in the Cayman Islands with principal executive offices in Frankfurt, Germany.

• CT Corporation System acts as the authorized U.S. representative.

Offering details and pricing

• Registration statement filed for a proposed public offering of securities as soon as practicable after effectiveness.

• The company is classified as an emerging growth company under the Securities Act.

• The offering includes both Class A and Class B Ordinary Shares.

Underwriters and syndicate

• The form of underwriting agreement will be filed as Exhibit 1.1.

• Underwriters will provide indemnification for certain liabilities arising under the Securities Act.